Pitavastatin
Also known as: Livalo, Livazo
A statin that lowers LDL cholesterol — and, unlike ezetimibe, also modestly raises HDL and lowers triglycerides. Often favored in the enhancement context for its comparatively clean interaction profile and minimal effect on blood sugar.
Substance family
Medications for blood pressure, lipids and glucose. They appear here because these are exactly the markers most anabolic compounds push in the wrong direction.
Effects on
Which outcomes this substance acts on — descriptive, not a recommendation.
Strain profile
Where this substance is most likely to hit — a rough orientation, individually dependent on dose, duration and predisposition.
This substance works against
Dosing & protocols by goal
Rough orientation ranges as reported in harm-reduction literature — not an individual treatment plan. Doses are individual and open-ended; frequency depends on the ester or half-life.
LDL control (on cycle)
AncillaryDose
1–4 mg / day
Frequency
1× / day
Cycle length
While LDL is elevated
Start low; often chosen over other statins for its minimal CYP interactions and small effect on glucose.
Side effect & countermeasure
Typical problems and what you can do to reduce harm — at a glance. Does not replace medical monitoring.
Problem
Muscle aches (myalgia)
Countermeasure
Usually mild; report severe or persistent pain, weakness or dark urine (rare rhabdomyolysis risk) and check CK if concerned.
Problem
Mildly raised liver enzymes
Countermeasure
Monitor ALT/AST; usually transient. Avoid stacking with heavy oral compounds and alcohol.
Overview
Pitavastatin is a statin used to lower LDL cholesterol. In the enhancement context it is popular because anabolic substances tend to worsen the lipid profile, and pitavastatin has a comparatively clean interaction profile and only a small effect on blood glucose.
Mechanism of Action
Like other statins, it inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, which lowers LDL. It is also one of the more HDL-favorable statins — it tends to raise HDL modestly and lower triglycerides, whereas ezetimibe mainly moves LDL. Pitavastatin is metabolized with minimal reliance on CYP3A4, so it interacts less with other compounds than some statins.
Typical Context
Used on cycle when LDL climbs despite cardio, diet, Omega-3 and Citrus Bergamot. It is a genuine medication and a medical decision — not a supplement to add casually.
Side Effects & Risks
- Muscle aches; rarely, serious muscle breakdown (rhabdomyolysis)
- Mild elevation of liver enzymes
- Interactions are fewer than with some statins, but still relevant
Blood Work & Monitoring
- Lipid profile (LDL, HDL, triglycerides) — to judge effect
- Liver values (ALT, AST)
- CK — if muscle symptoms appear
Harm-Reduction Notes
- Address lifestyle first (cardio, diet, Omega-3); medication is for when that isn't enough
- Start at a low dose and recheck lipids and liver values
- Decide with a physician, especially alongside other hepatically stressful compounds
Legal status by region
Regulation differs considerably between jurisdictions and changes over time. This is a rough orientation, not legal advice — check the rules that apply where you are.
| Region | Regulatory status |
|---|---|
| United States | Prescription-only medicineApproved for defined indications; use outside them is off-label. |
| EU / UK | Prescription-only medicineApproved for defined indications. |
| Canada / Australia | Prescription-only medicine |
| Parts of Asia, Latin America & Middle East | Pharmacy availability variesSeveral countries dispense it without prescription in practice. Rules and enforcement differ and change. |
| Competitive sport | Check the current WADA listSome substances in this class are prohibited, others are not. |